How much is NewBridge Pharmaceuticals worth in 2026?

NewBridge Pharmaceuticals has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has NewBridge Pharmaceuticals raised?

NewBridge Pharmaceuticals has raised N/A in total funding across 1 funding rounds.

NewBridge Pharmaceuticals

Pharmaceuticals

Current Valuation

N/A

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC

$4.0M

Last Funding

Unknown

Funding date

Capital Efficiency

N/A

Valuation / Funding

Interested in buying or selling NewBridge Pharmaceuticals shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Early Stage VC	$4.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

NewBridge Pharmaceuticals is currently valued at N/A.

Explore More Data

Detailed analysis for NewBridge Pharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

What is NewBridge Pharmaceuticals Worth in 2026?

NewBridge Pharmaceuticals is a leading private company in the Pharmaceuticals sector. Track NewBridge Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How NewBridge Pharmaceuticals Valuation is Determined

Private company valuations like NewBridge Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.